Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04902092
Other study ID # 12563
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 23, 2019
Est. completion date November 21, 2022

Study information

Verified date October 2023
Source Monash University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Heavy cannabis use is associated with substantive learning and memory impairments and elevated risk of psychopathology. It has been repeatedly demonstrated that the hippocampus, centrally implicated in these processes, is particularly vulnerable to the deleterious effects of prolonged exposure to cannabis. This deterioration of hippocampal structure, function, and biochemistry can be reversed, but this requires two or more years of abstinence from cannabis. However, most heavy cannabis users find it extremely difficult to maintain abstinence over extended periods and current treatments for cannabis use disorders are inadequate. There is a pressing clinical need for an intervention that rapidly accelerates hippocampal recovery, ameliorates the associated cognitive impairments and mental health symptoms, and leads to improved treatment outcomes. One promising candidate is physical exercise. In addition to the well-known physical health benefits, regular exercise also has a potent positive effect on brain health. The current study will investitive the capacity of two different neuroscientifically-informed 12-week exercise programs can restore brain health for heavy long term cannabis users.


Description:

Heavy cannabis use is associated with substantive learning and memory impairments and elevated risk of psychopathology. It has been repeatedly demonstrated that the hippocampus, centrally implicated in these processes, is particularly vulnerable to the deleterious effects of prolonged exposure to cannabis. This deterioration of hippocampal structure, function, and biochemistry can be reversed, but this requires two or more years of abstinence from cannabis. However, most heavy cannabis users find it extremely difficult to maintain abstinence over extended periods and current treatments for cannabis use disorders are inadequate. There is a pressing clinical need for an intervention that rapidly accelerates hippocampal recovery, ameliorates the associated cognitive impairments and mental health symptoms, and leads to improved treatment outcomes. One promising candidate is physical exercise. In addition to the well-known physical health benefits, regular exercise also has a potent positive effect on brain health and can increase the size of the hippocampus. It's not yet known how much or what kind of exercise produces the best results. This study has been designed to compare the effects of two different exercise programs. 1. 12 weeks of regular HIIT exercise 2. 12 weeks of regular strength training The research team are investigating whether the programs have a positive impact on brain health and, if they do, whether one is more effective than the other. The research team will also measure whether engaging in either program leads to a reduction in cannabis consumption, and improvements in thinking skills, mental health, and general wellbeing.


Recruitment information / eligibility

Status Completed
Enrollment 65
Est. completion date November 21, 2022
Est. primary completion date June 10, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 55 Years
Eligibility Inclusion Criteria: 1. Aged 20-55 years 2. Voluntary and able to provide informed consent 3. Fluent in English 4. Current moderate - severe cannabis use disorder 5. Major history of cannabis use (i.e. =3 days per week on average for =4 of the past 6 years) 6. Capacity to tolerate physical exercise according to 'Fitness to Exercise' Exclusion Criteria: 1. Have a history of cardiovascular disease, high blood pressure, musculoskeletal injury or other condition that would preclude safe engagement in VO2 max fitness testing and/or regular physical exercise 2. Severe claustrophobia, non-MR compatible metallic implant, or other contraindication to MRI scanning 3. Lifetime history of significant neurological illness, or moderate - severe brain injury, 4. Current major unstable medical illness or chronic pain condition 5. Lifetime history of schizophrenia, schizoaffective disorder, OCD, PTSD, bipolar disorder 6. Current significant depression or anxiety that precludes ability to reliably engage in the exercise program 7. Current moderate - severe substance use disorder for substances other than cannabis (excluding nicotine) 8. Currently pregnant or lactating 9. Shift work employment schedule within the prior 6-months 10. Have engaged in =5 sessions of HITT or resistance training within the past 12-months 11. History of treatment with antipsychotic medications 12. Current participation in psychosocial treatment for substance use disorder 13. Other psychoactive medications or psychosocial treatments will be considered on a case-by-case basis. Where a current psychoactive medication is deemed acceptable, both dose and type must have been stable for a minimum of four weeks prior to baseline assessment, and remain stable throughout the 12-week exercise phase of the study.

Study Design


Intervention

Behavioral:
High Intensity Interval Training
Exercise sessions will commence with an initial 3-week accustomization period whereby training load will increase incrementally from 2 x 45min sessions with effort peaking at 60% VO2 max (week 1) increasing to 3 x 45minute with effort peaking at 80% VO2max (week 3). Participants will transition to the full HIIT protocol for the remaining weeks. The HIIT component will comprise a work-rest ratio of =1:1minutes, with alternating exertion epochs at >80% VO2max and <60% VO2max. As VO2max is likely to increase as fitness improves toward the end of the 3-month program, adjustments to HIIT will be made by the exercise physiologist based on real-time heart rate monitoring, ensuring greater accuracy in participants achieving their heart rate targets.
Strength and Resistance Training
Exercise sessions will comprise a combination of strength, coordination and mobility exercises. The strength component will consist of 2-3 sets of resistance exercises at =70% of a predicted 1 repetition maximum, targeting all body segments. Heart rate tracking will occur to ensure participants do not exceed 70% v02 (or exceed Lactate Threshold).

Locations

Country Name City State
Australia Monash University, BrainPark Melbourne Victoria

Sponsors (2)

Lead Sponsor Collaborator
Monash University Turning Point

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in hippocampal integrity Composite score derived from three hippocampal health indices: volume (structural MRI), connectivity (DTI), neuronal health (MRS NAA) calculated as described in Yucel et al (2016), doi:10.1038/tp.2015.201. Baseline (0 months), post (3 months)
Secondary Change in cannabis use Time line follow back Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in cannabis dependence Severity of Dependence Scale (SDS; range = 0-15 higher scores indicate higher dependence Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in cannabis craving Penn Craving Scale (PCS; range = 0 - 30 higher scores indicate greater craving) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in depression symptoms Quick Inventory of Depressive Symptomology (QUIDS; range = 0 - 27 higher scores indicate greater depression symptom severity) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in anxiety symptoms StateTrait Anxiety Inventory (STAI; range = 20 to 80, higher scores indicate greater anxiety) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in resilience Connor David Resilience Scale (CDRS; range = 0-100 higher scores indicate higher resilience) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in coping skills Perceived Stress Scale (10 item; range = 0 - 40 higher scores indicate greater stress) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in sleep quality Pittsburgh Sleep Quality Index (PSQI; range = 0 to 21 higher scores indicate worse sleep quality) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in mental wellbeing Warwick Edinburgh Mental Wellbeing Scale (WEMWBS; range = 14-70 higher scores indicate increased mental well being) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in quality of life Quality of Life and Satisfaction Questionnaire - Short Form (QOL-SF; range = 70 higher scores indicate greater life satisfaction and enjoyment) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in memory Rey Auditory Verbal Learning Test (RAVLT) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in associative memory Paired Associates Learning Task (PAL) Baseline (0 months), post (3 months), follow up (6 months)
Secondary Change in visual memory Figural Memory Tasks Baseline (0 months), post (3 months)
Secondary Change in cardiorespiratory fitness VO2 max Baseline (0 months), post (3 months)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04106336 - Cortical Excitability and Role of rTMS in Cannabis Use Disorder Early Phase 1
Recruiting NCT04964739 - Gender/Sex & CUD Remission N/A
Not yet recruiting NCT06225232 - Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study Phase 2
Completed NCT04923230 - Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse N/A
Recruiting NCT05064319 - Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders Phase 2
Active, not recruiting NCT04567394 - Cannabis Use Disorder Treatment Study N/A